RAD51AP1 and breast carcinoma: RAD51AP1 expression is increased in different breast cancer subtypes and other cancers and inversely associated with overall survival (Song et al., 2004; Henson et al., 2006; Martin et al., 2007; Martinez et al., 2007; Obama et al., 2008; Pathania et al., 2016; Chudasama et al., 2018; Li et al., 2018; Bridges et al., 2020; Zhao et al., 2020; Zhuang et al., 2020).